SCHEMBL5034227

SCHEMBL5034227

CCCCOc1ccc(O[SiH3])c(OCCCC)c1OCCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ GLA P06280 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ MCHR1 Q99705 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CHRM2 P08172 2/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034245 0.90 CSNK2A1 (0.43) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL1984241 0.89 CYP1A2 (0.52) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL5032298 0.82 LMNA (0.43) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL8220033 0.80 ALDH1A1 (0.44) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL8223215 0.79 CYP1A2 (0.47) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL8224344 0.78 ALDH1A1 (0.43) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL1236256 0.78 CYP1A2 (0.56) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL30957371 0.78 ESR1 (0.49) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL1837743 0.78 ESR1 (0.49) LMNAKDM4EALDH1A1MAPTNPSR1
SCHEMBL28589559 0.78 CYP1A2 (0.60) LMNAKDM4EMAPTNPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 — — EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 — — WO disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 — — US disclosed
Send feedback